Identification | Back Directory | [Name]
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | [CAS]
289472-81-7 | [Synonyms]
Bortezomib EP IMP M Bortezomib USP IMP J Bortezomib Impurity J Bortezomib Impurity D Bortezomib Impurity 48 Bortezomib USP Impurity J BortezomibHydroxy(1S,2S)-Isomer Bortezomib USP Related Compoud J (S)-Hydroxy Des(boric Acid) BortezoMib (S,S)-Bortezomib Hydroxyisopentyl Amide Analog N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylprop (N-[(1S)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazi N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- Bortezomib Related Compund J/ (S,S)-Bortezomib Hydroxyisopentyl Amide Analog (Bortezomib Hydroxy S,S-Isomer Impurity) | [Molecular Formula]
C19H24N4O3 | [MOL File]
289472-81-7.mol | [Molecular Weight]
356.42 |
Hazard Information | Back Directory | [Uses]
(S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
|
Company Name: |
OPULENT PHARMA
|
Tel: |
+91-9106692785 +91-9106692785 |
Website: |
www.www.NOWEBSITE |
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
Company Name: |
Alputon Inc.
|
Tel: |
021-60753308-14013 |
Website: |
www.is0513.com/ShowSupplierProductsList13466/0.htm |
|